TrialThorax2018

Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury.

Alastair Proudfoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.